HomeCompareLIOPY vs EQR

LIOPY vs EQR: Dividend Comparison 2026

LIOPY yields 1.43% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQR wins by $238.00 in total portfolio value
10 years
LIOPY
LIOPY
● Live price
1.43%
Share price
$16.40
Annual div
$0.23
5Y div CAGR
38.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.2K
Annual income
$6,267.32
Full LIOPY calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — LIOPY vs EQR

📍 EQR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLIOPYEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LIOPY + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LIOPY pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LIOPY
Annual income on $10K today (after 15% tax)
$121.42/yr
After 10yr DRIP, annual income (after tax)
$5,327.22/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, LIOPY beats the other by $2,080.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LIOPY + EQR for your $10,000?

LIOPY: 50%EQR: 50%
100% EQR50/50100% LIOPY
Portfolio after 10yr
$40.3K
Annual income
$5,043.46/yr
Blended yield
12.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

LIOPY
No analyst data
Altman Z
3.1
Piotroski
8/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LIOPY buys
0
EQR buys
0
No recent congressional trades found for LIOPY or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLIOPYEQR
Forward yield1.43%4.73%
Annual dividend / share$0.23$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.2%15.8%
Portfolio after 10y$40.2K$40.5K
Annual income after 10y$6,267.32$3,819.61
Total dividends collected$17.9K$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LIOPY vs EQR ($10,000, DRIP)

YearLIOPY PortfolioLIOPY Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$10,897$197.41$11,248$547.57$351.00EQR
2$11,938$277.85$12,701$666.53$763.00EQR
3$13,167$393.14$14,405$814.59$1.2KEQR
4$14,649$560.04$16,413$999.84$1.8KEQR
5$16,479$804.74$18,795$1,232.92$2.3KEQR
6$18,802$1,169.25$21,639$1,527.95$2.8KEQR
7$21,841$1,723.06$25,057$1,903.80$3.2KEQR
8$25,955$2,585.22$29,197$2,385.87$3.2KEQR
9$31,740$3,968.01$34,250$3,008.70$2.5KEQR
10$40,229$6,267.32$40,467$3,819.61$238.00EQR

LIOPY vs EQR: Complete Analysis 2026

LIOPYStock

Lion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through three segments: Consumer Products Business, Industrial Products Business, and Overseas Business. The company offers dental and oral care products, including toothpastes, toothbrushes, dental floss, dental rinses, mouthwashes and breath fresheners, periodontitis ointments, and denture products; body care products, such as shampoos and conditioners, hand soaps, sanitizers, wet wipes, body washes, skin and acne care products, antiperspirants and deodorants, hair-nourishment treatments, men's care and toiletries products, and foot care products. It also provides antipyretic analgesics, eye drops and eye care products, cold medicines, gargles, cold relief products, topical anti-inflammatory analgesics, antidiarrheal and gastrointestinal medicines, health tonic drinks and vitamin supplements, acne and anti-drowsiness medicines, and dermatologic agents. In addition, the company offers fabric care products, such as laundry detergent, delicate detergent, prewash treatment, stain remover, bleach, and fabric softener; clothing care products; household cleaners; kitchen cleanup products comprises dishwashing detergents and antibacterial and deodorizing products; and food preparation products. Further, it provides health and beauty food products consisting of supplements and health tonic drinks; specialty chemicals, and chemical products, include rubber processing and additive agents, mandrel release agents, fatty acid methyl esters, plant-based electrical insulating oils, concrete admixtures, ground improvement and asphalt recycling agents, surfactants, and cosmetics ingredients, as well as electro-conductive carbon black and pressure-sensitive adhesives; pet supplies; and gift and special order products. The company was founded in 1891 and is headquartered in Tokyo, Japan.

Full LIOPY Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this LIOPY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LIOPY vs SCHDLIOPY vs JEPILIOPY vs OLIOPY vs KOLIOPY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.